Table 1.
Characteristic | Number (%) |
---|---|
Age (y) | |
>44 | 163 (47.2) |
≤44 | 182 (52.8) |
Sex | |
Female | 96 (27.8) |
Male | 249 (72.2) |
Pretreatment thyroid volume, cm3 | |
>16 | 178 (51.6) |
≤16 | 167 (48.4) |
WHO pathologic type | |
Undifferentiated nonkeratinizing | 343 (99.4) |
Differentiated nonkeratinizing | 2 (0.6) |
Tumor classificationa | |
T1 | 59 (17.1) |
T2 | 68 (19.7) |
T3 | 147 (42.6) |
T4 | 71 (20.6) |
Node classificationa | |
N0 | 54 (15.7) |
N1 | 167 (48.4) |
N2 | 79 (22.9) |
N3 | 45 (13.0) |
Overall stagea | |
I | 23 (6.7) |
II | 67 (19.4) |
III | 150 (43.5) |
IV | 105 (30.4) |
Mean radiation dose (Gy) | |
>47 | 162 (47.0) |
≤47 | 183 (53.0) |
Maximum radiation dose (Gy) | |
>63 | 155 (44.9) |
≤63 | 190 (55.1) |
Minimum radiation dose (Gy) | |
>26 | 172 (49.9) |
≤26 | 173 (50.1) |
Chemotherapy | |
Yes | 293 (84.9) |
No | 52 (15.1) |
Abbreviation: WHO, World Health Organization.
According to the Union for International Cancer Control/American Joint Committee on Cancer criteria (8th version).